Research
Metabolic adaptation
Laparoscopic Roux-en-Y gastric bypass provides superior long-term remission of dyslipidaemia, hypertension, and gastro-oesophageal reflux disease compared to laparoscopic sleeve gastrectomy.
Surgeons should consider Roux-en-Y gastric bypass for patients with specific comorbidities.
StrongSupportsmedium confidence
Laparoscopic Roux-en-Y gastric bypass provides superior long-term remission of dyslipidaemia, hypertension and gastro-oesophageal reflux disease compared to laparoscopic sleeve gastrectomy (SG).
Why this rating
Based on comparative effectiveness data from included studies.
Source
The evolving landscape of metabolic surgery: An evidence-based review
Vidit Dholakia et al. · Journal of Minimal Access Surgery · 2026
Meta-analysis
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →